Teva Pharma plan risks 38 jobs but other plants safe

Teva Pharmaceuticals — the generics drug giant and maker of Sudocrem — will close one of two laboratories in Dundalk but major manufacturing plants in Waterford and at Baldoyle in Dublin appear safe amid a worldwide cost-cutting review.

In Ireland, the drugs firm said earlier this week that its plans to close a testing laboratory at the Xerox Technology Park in Dundalk next year potentially puts at risk 38 of the 51 jobs at the facility.

It said that the Dundalk decision came after it completed the acquisition of Actavis last August as it sets up a single European testing laboratory in Zagreb, the Croatian capital, on the basis of costs.